Merck (MRK) Non-Current Assets (2009 - 2026)

Merck has disclosed Non-Current Assets across 18 years of filings, most recently posting $125.0 million for Q1 2026.

• In Q1 2026, Non-Current Assets fell 99.84% year-over-year to $125.0 million; the TTM figure through Mar 2026 stood at $125.0 million (down 99.96% YoY), while the FY2025 annual figure was $125.0 million, changed N/A from the prior year.
• Non-Current Assets was little changed at $125.0 million in Q1 2026, from $125.0 million in the prior quarter.
• Over the last five years, Non-Current Assets for MRK reached as high as $82.0 billion in Q3 2025 and fell as low as $125.0 million in Q4 2025.
• The 5-year median for Non-Current Assets is $74.5 billion (2023), against an average of $66.5 billion.
• Annual changes were most pronounced in 2022 — Non-Current Assets climbed 20.89% — and 2026, when it sank 99.84%.
• A 5-year view of Non-Current Assets shows it stood at $73.4 billion in 2022, then grew by 1.46% to $74.5 billion in 2023, then increased by 3.58% to $77.2 billion in 2024, then tumbled by 99.84% to $125.0 million in 2025, then changed by 0.0% to $125.0 million in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $125.0 million, $125.0 million, and $82.0 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.